Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 34Prostatic Neoplasms, Castration-Resistant 3Metastatic Castration-resistant Prostate Cancer 2Metastatic Castration-Resistant Prostate Cancer 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Prostate Cancer Metastatic Disease 1Prostate Adenocarcinoma 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoadjuvant Therapy 1Metastatic Hormone-sensitive Prostate Cancer 1Melanoma 1Disease 1Castration-resistant Prostate Cancer 1Castrate Sensitive Prostate Cancer 1Carcinoma, Small Cell 1Carcinoma, Non-Small-Cell Lung 1Anus Neoplasms 1

Interventions

apalutamide 1abiraterone 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostate Cancer Metastatic Disease × abiraterone × Clear all
NCT06832774 2026-03-25

Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
192 enrolled
Genitourinary

Prostate Cancer Metastatic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡